OABI:NASDAQ, OmniAb, Inc.
OABI stock overview
OmniAb, Inc. (OABI:NASDAQ) closed at $4.66 on October 23, 2026,
down 2.51% on the day.
The stock trades 14.2% below its 52-week high of $5.43
and 258.5% above its 52-week low of $1.30.
Over the past year, it gained 185.9%.
OmniAb, Inc. is part of the Health Care sector.
Key figures
- Price
- $4.66
- Day change
- -2.51%
- Volume
- 1,282,974
- Average volume
- 1,596,489
- Market cap
- 677M+
- 52-week range
- $1.30 – $5.43
- 50-day average
- $4.52
- 200-day average
- $2.61
Price action over the past year
In 252 trading sessions since October 23, 2025, OABI closed higher on 117 days (46%).
Its best day was August 7, 2026 (+37.50%) and its worst was October 6, 2026 (-11.59%).
The stock moved 10% or more in a single session 12 times.
It opened at least 5% above the previous day's high 1 time.
Recent signals
OABI news
-
Oct 22, 2026:
OmniAb Faces Quieter Milestone Quarter After A Doubling Stock And Three Guidance Raises
-
Oct 14, 2026:
OmniAb to Report Third Quarter 2026 Financial Results on October 30
-
Oct 7, 2026:
OmniAb Investor Day Spotlights Royalty Pipeline, OmniTides Launch and xPloration Growth
-
Oct 6, 2026:
All You Need to Know About OmniAb, Inc. (OABI) Rating Upgrade to Buy
-
Oct 6, 2026:
OmniAb Highlights Partner Pipeline, xPloration® Plans and Outlook, and Introduces the OmniTides™ Platform at Investor & Analyst Day
-
Oct 6, 2026:
OmniAb Highlights Partner Pipeline, xPloration Plans and Outlook, and Introduces the OmniTides Platform at Investor & Analyst Day
-
Sep 14, 2026:
OmniAb to Host Investor & Analyst Day on October 6, 2026
-
Aug 28, 2026:
Is OmniAb (OABI)'s Eli Lilly (LLY) Partnership a Game Changer for OABI?
About OmniAb, Inc.
OmniAb Inc offers best-in-class therapeutic antibody discovery technologies.
Similar stocks
Find more stocks like OABI with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.